473
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Factors influencing recovery from mild traumatic brain injury

ORCID Icon, , &
Pages 1202-1212 | Received 18 Apr 2019, Accepted 11 Jul 2020, Published online: 23 Jul 2020

References

  • Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Surveillance report of traumatic brain injury-related emergency department visits, hospitalizations, and deaths—United States. Washington (DC): Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2014 [accessed 13 April 2019]. https://www.cdc.gov/traumaticbraininjury/pdf/TBI-Surveillance-Report-FINAL_032919.pdf
  • Bazarian JJ, Cernak I, Noble-Haeusslein L, Potolicchio S, Temkin N. Long-term neurologic outcomes after traumatic brain injury. J Head Trauma Rehabil. 2009;24:439–51. doi:10.1097/HTR.0b013e3181c15600.
  • Le TH, Wintermark M, Gean AD. Focal lesions in acute mild TBI and neurocognitive outcome: CT versus 3T MRI. J Neurotrauma. 2008;25:1049–56. doi:10.1089/neu.2008.0566. Cited in: PMID: 18707244.
  • Faul M, Xu L, Wald MM, Coronado VG. Traumatic brain injury in the United States: emergency department visits, hospitalizations and deaths 2002–2006. Atlanta (GA): Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2010.
  • Wardlaw JM, Easton VJ, Statham P. Which CT features help predict outcome after head injury? J Neurol Neurosurg Psychiatry. 2002;72:188–92. doi:10.1136/jnnp.72.2.188.
  • Hergenroeder GW, Moore AN, McCoy JP Jr, Samsel L, Ward NH 3rd, Clifton GL, Dash PK. Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation. 2010;7. doi:10.1186/1742-2094-7-19.
  • Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet. 1974;2:81–84. doi:10.1016/s0140-6736(74)91639-0.
  • Bryant RA. Disentangling mild traumatic brain injury and stress reactions. N Engl J Med. 2008;358:525–27. doi:10.1056/NEJMe078235.
  • Wilson J, Pettigrew L, Teasdale G. Structured interviews for the glasgow outcome scale and the extended glasgow outcome scale: guidelines for their use. J Neurotrauma. 1998;15(8):573–85. doi:10.1089/neu.1998.15.573. Cited in: PMID: 9726257.
  • Wijdicks EFM. Clinical scales for comatose patients: the glasgow coma scale in historical context and the new FOUR score. Rev Neurol Dis. 2006;3:109–17. Cited in: PMID: 17047576.
  • Woertgen C, Rothoerl R, Metz C, Brawanski A. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J Trauma. 1999;47(6):1126–30. doi:10.1097/00005373-199912000-00026.
  • Stocchetti N, Pagan F, Calappi E, Canavesi K, Beretta L, Citerio G, Cormio M, Colombo A. Inaccurate early assessment of neurological severity in head injury. J Neurotrauma. 2004;21:1131–40. doi:10.1089/neu.2004.21.1131.
  • Commerford V, Geffen G, May C, Medland S, Geffen L. A rapid screen of severity of mild traumatic brain injury. J Clin Exp Neuropsychol. 2002;24:409–19. doi:10.1076/jcen.24.4.409.1044.
  • Delaney JS, Abuzeyad F, Correa JA, Foxford R. Recognition and characteristics of concussions in the emergency department population. J Emerg Med. 2005;29:189–97. doi:10.1016/j.jemermed.2005.01.020.
  • Boake C, High WM. Functional outcome from TBI- unidimensional or multidimensional? Am J Phys Med Rehab. 1996;75:105–13. doi:10.1097/00002060-199603000-00005.
  • Sherer M, Novack TA, Sander AM, Struchen MA, Alderson A, Thompson RN. Neuropsychological assessment and employment outcome after traumatic brain injury: a review. Clin Neuropsychol. 2002;16(2):157–78. doi:1385-4046/02/1602/15716.00.
  • Ponsford J, Willmott C, Rothwell A. Impact of early intervention on outcome following mild head injury in adults. J Neurol Neurosurg Psychiatry. 2002;73:330–32. doi:10.1136/jnnp.73.3.330.
  • Wade DI, King NS, Wendon FJ. Routine follow up after head injury: a second randomized controlled trial. J Neurol Neurosurg Psychiatry. 1998;65:177–83. doi:10.1136/jnnp.65.2.177.
  • Teasdale GM, Murray GD, Nicoll JAR. The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study. Brain. 2005;128:2556–61. doi:10.1093/brain/awh595.
  • Eisenstein M. Genetics: finding risk factors. Nature. 2011;475(7355):S20–S22. doi:10.1038/475S20a. Cited in: PMID: 21760580.
  • Horsburgh K, Cole G, Yang F, Savage M, Greenburg B, Gentleman S, Graham D, Nicoll J. Beta amyloid AB42/43, AB 40 and apoE immunostaining of plaques in fatal head injury. Neuropathol Appl Neurobiol. 2001;26:124–32. doi:doi.10.1046/j.1365-2990.2000.026002124.x.
  • Ponsford J, McLaren A, Schonberger M, Burke R, Rudzki D, Olver J, Ponsford M. The association between ApoE and traumatic brain injury severity and functional outcome in a rehabilitation sample. J Neurotrauma. 2011;28(9):1683–92. doi:10.1089/neu.2010.1623.
  • Ramanan VK, Risacher SL, Nho K, Kim S, Swaminathan S, Shen L, Foroud TM, Hakonarson H, Huentelman MJ, Aisen PS, et al. Alzheimer’s disease neuroimaging initiative. APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study. Mol Psychiatry. 2014;19(3):351–57. doi:10.1038/mp.2013.19.
  • Guo L, LaDu MJ, VanEldik LJ. A dual role for apoe in neuroinflammation: anti and pro-inflammatory activity. J Mol Neurosci. 2004;23:205–12. doi:10.1385/JMN:23:3:205. Cited in: PMID: 15181248.
  • Jofre-Monseny L, Minihane AM, Rimbach G. Impact of APOE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res. 2008;52(1):131–45. doi:10.1002/mnfr.200700322.
  • Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD. Gene dose of apolipoprotein E type 4 allele and the risk of alzheimer’s disease in late onset families. Science. 1993;261:921–23. doi:10.1126/science.8346443.
  • Arendt T, Schindler C, Brückner M, Eschrich K, Bigl V, Zedlick D, Marcova L. Plastic neuronal remodeling is impaired in patients with alzheimer’s disease carrying apolipoprotein ε4 allele. J Neurosci. 1997;17:516–29.
  • Bennett D, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE, Cochran EJ, Berry-Kravis E, Bienias JL. ApoEe4 allele, AD pathology, and the clinical expression of alzheimer’s disease. Neurology. 2003;60:246–52. doi:00006114-200301280-00021.
  • Breitner J, Wyse B, Anthony J, Welsh-Bohmer K, Steffens D, Norton M, Tschanz JT, Plassman BL, Meyer MR, Skoog I, et al. APOE- 4 count predicts age when prevalence of AD increases, then declines: the cache county study. Neurology. 1999;53(2):321–31. doi:10.1212/WNL.53.2.321.
  • Jonker C, Schmand B, Lindeboom J, Havekas LM, Launer LJ. Association between APOEe4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch Neurol. 1998;55:1065–69. doi:10.1001/archneur.55.8.1065.
  • Houlden H, Greenwood R. Apolipoprotein E4 and traumatic brain injury. J Neurol Neurosurg Psychiatry. 2006;77:1106. doi:10.1136/jnnp.2006.095513.
  • Liaquat I, Dunn LT, Nicoll JA, Teasdale GM, Norris JD. Effect of APOE genotype on hematoma volume after trauma. J Neurosurg. 2002;96:90–96. doi:10.3171/jns.2002.96.1.0090.
  • Jiang Y, Sun XC, Gui L, Tang WY, Zhen LP, Gu YJ, Wu HT. Lack of association between APOE promoters in E4 carriers and worsening on computed tomography in early stage of traumatic brain injury. Acta Neurochi Suppl. 2008;105:233–36. doi:10.1007/978-3-211-09469-3_45.
  • Sorbi S, Nacmias B, Piacentini S, Repice A, Latorraca S, Forleo P, Amaducci L. ApoE as a prognostic factor for post-traumatic coma. Nat Med. 1995;1:852–563. doi:10.1038/nm0995-852.
  • Jiang Y, Sun XC, Xia Y, Tang W, Cao Y, Gu Y. Effect of APOE polymorphisms on early responses to traumatic brain injury. Neurosci Lett. 2006;408:155–58. doi:10.1016/j.neulet.2006.08.082.
  • Crawford FC, Vanderploeg RD, Freeman MJ, Singh S, Waisman M, Michaels L, Abdullah L, Warden D, Lipsky R, Salazar A, et al. APOE genotype influences acquisition and recall following traumatic brain injury. Neurology. 2002;58:1115–18. Cited in: PMID: 11940706.
  • Chiang MF, Chang JG, Hu CJ. Association between apoe genotype and outcome of traumatic brain injury. Acta Neurochir (Wien). 2003;145:649–54. doi:10.1007/s00701-003-0069-3.
  • Ost M, Nylen K, Casjbok L, Blennow K, Rosengren L, Nellgard B. ApoE polymorphism and gender difference in outcome after severe traumatic brain injury. Acta Anaestesial Scand. 2008;52:1364–69. doi:10.1111/j.1399-6576.2008.01675.x.
  • Noe E, Ferri J, Colomer C, Miliner B, Chirivella J. ApoE genotype and verbal memory recovery during and after emergence from post-traumatic amnesia. Brain Inj. 2010;24:886–92. doi:10.3109/02699051003724952.
  • Hiekkanen H, Kurki T, Brandstack N, Kairisto V, Tenovuo O. Association of injury severity, MRI-results, and ApoE genotype with 1-year outcome in mainly mild TBI: a preliminary study. Brain Inj. 2009;23:396–402. doi:10.1080/026990590902926259.
  • Shadli RM, Pieter MS, Yaacob MJ, Rashid FA. ApoE genotype and neuropsychological outcome in mild-to-moderate traumatic brain injury: A pilot study. Brain Inj. 2011;25(6):598–603. doi:10.3109/02699052.2011.572947.
  • Alberts M, Graffagnino C, McClenny C, DeLong D, Strittmatter W, Saunders A, Roses A. ApoE genotype and survival from intracerebral haemorrhage. Lancet. 1995;346(8974):575. doi:10.5555/uri:pii:S0140673695914110. Cited in: PMID: 7658797.
  • Ariza M, Pueyo R, Matarin MM, Junque C, Mataro M, Clemente I, Moral P, Poca MA, Garnacho A, Sahuquillo J. Influence of Apoe polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury. J Neurol Neurosurg Psychiatry. 2006;77:1191–93. doi:10.1136/jnnp.2005.085167.
  • Teasdale GM, Nicoll JA, Murray G, Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet. 1997;350:1069–71. doi:10.1016/s0140-6736(97)04318-3.
  • Iverson GL, Brooks BL, Lovell MR, Collins MW. No cumulative effects for one or two previous concussions. Br J Sports Med. 2006;40:72–75. doi:10.1136/bjsm.2005.020651.
  • Thomas DG, Collins MW, Saladino RA, Frank V, Raab J, Zuckerbraun NS. Identifying neurocognitive deficits in adolescents following concussion. Acad Emerg Med. 2011;18:246–54. doi:10.1111/j.1553-2712.2011.01015.x.
  • Nance ML, Pol-Williams A, Collins MW, Wiebe DJ. Neurocognitive evaluation of mild traumatic brain injury in the hospitalized pediatric population. Ann Surg. 2009;249:859–63. doi:10.1097/SLA.0b013e3181a41ae5.
  • Impact Administration and Interpretation Manual 2011. 2017 Feb 7 [Last accessed 2019 April 4]. www.impacttest.com.
  • Rappaport M, Hall KM, Hopkins K, Belleza T, Cope DN. Disability rating scale for severe head trauma: coma to community. Arch Phys Med Rehabil. 1982;63:118–23. Cited in: PMID: 7073452.
  • Brictova E, Kozak L. ApoE genotype and traumatic brain injury in children – association with neurological outcome. Childs Nerv Syst. 2008;24:349–54. doi:10.1007/s00381-007.0459.6.
  • Alexandre A, Colombo F, Nertempi P, Benedtti A. Cognitive outcome and early indices of severity of head injury. J Neurosurg. 1983;59:751–61. doi:10.3171/jns.1983.59.5.0751. Cited in: PMID: 6619927.
  • Chamelian L, Reis M, Feinstein A. Six-month recovery from mild to moderate traumatic brain injury: the role of APOE-epsilon 4 allele. Brain. 2004;127:2621–28. doi:10.1093/brain/awh296.
  • Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991;337:1158–59. doi:10.1016/0140-6736(91)92823-k.
  • Lescai F, Chiamenti AM, Codemo A, Pirassini D, D’Agostino G, Ruaro C, Ghidoni R, Benussi L, Galimberti D, Esposito F, et al. An APOE haplotype associated with decreased e4 expression increases the risk of late onset alzheimer’s disease. J Alzheimer’s Dis. 2011;24:235–45. doi:10.3233/JAD-2011-101764. Cited in: PMID: 21263195.
  • Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE. The role of APOEe4 in longitudinal cognitive decline. Neurology. 2003;60:1077–81. doi:00006114-200304080-0000.
  • Elias-Sonnenschein LS, Veichtbauer W, Ramakers I, Verhey FRJ, Visser PJ. Predictive value of APOEe4 allele for progression from MCI to AD-type dementia: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82(10):1149–56. doi:10.1136/jnnp.2010.231555.
  • Hiekkanen H, Kurki T, Brandstack N, Kairisto V, Tenovuo O. MRI changes and APOE genotype, a prospective 1-year follow-up of traumatic brain injury: a pilot study. Brain Inj. 2007;21(12):1307–14. doi:10.1080/02699050701739549.
  • Liberman JN, Stewart WF, Wesnes K, Troncoso J. Apolipoprotein E e4 and short-term recovery from predominantly mild brain injury. Neurology. 2002;58:1038–44. Cited in: PMID: 11940689.
  • Smith D, Graham DI, Murray LS, Stewart J, Nicoll JAR. Association of APOE e4 and cerebrovascular pathology in traumatic brain injury. J Neurol Neurosurg Psychiatry. 2006;77:363–66. doi:10.1136/jnnp.2005.074617.
  • Sundstrom A, Nilsson LG, Cruts M, Adolfsson R, van Broeckhoven C, Nyberg L. Fatigue before and after mild TBI: pre-post-injury comparisons in relation to APOE. Brain Inj. 2007;21:1049–54. doi:10.1080/02699050701630367.
  • Van Der Naalt J, Hew J, Van Zomeren A, Sluiter W, Minderhoud J. Computed tomography and magnetic resonance imaging in mild to moderate head injury: early and late imaging related to outcome. Ann Neurol. 1999;46(1):70–78. doi:10.1002/1531-8249(199907)46:1<70::aid-ana11>3.0.co;2-l.
  • McCullagh S, Oucherlony D, Protzner A, Blair N, Feinstein A. Prediction of neuropsychiatric outcome following mTBI: an examination of the GCS. Brain Inj. 2001;15:489–97. doi:10.1080/02699050010007353. Cited in: PMID: 11394968.
  • Fisher J, Mathieson C. The history of the GCS: implications for practice. Crit Care Nurs Q. 2001;23:52–58. Cited in: PMID: 11852950.
  • Shores EA, Lammel A, Hullick C, Sheedy J, Flynn M, Levick W, Batchelor J. The diagnostic accuracy of the revised westmead PTA scale as an adjunct to the glasgow coma scale in the early identification of cognitive impairment in patients with mild traumatic brain injury. J Neurol Neurosurg Psychiatry. 2008;79(10):1100–06. doi:10.1136/jnnp.2007.132571.
  • Mena JH, Sanchez AI, Rubiano AM, Peitzman AB, Sperry JL, Gutierrez MI, Puyana JC. Effect of the modified GCS score criteria for mild TBI on mortality prediction: comparing classic and modified GCS score model scores of 13. J Trauma. 2011;71:1193. doi:10.1097/TA.0b013e31823321f8.
  • Drake AI, McDonald EC, Magnus NE, Gray N. Gottshall K Utility of GCS-extended in symptom prediction following mTBI. Brain Inj. 2006;20:469–75. doi:10.1080/02699050600676370.
  • Brown CV, Zada G, Salim A, Inaba K, Kasotakis G, Hadjizacharia P, Demetriades D, Rhee P. Indications for routine repeat head CT stratified by severity of TBI. J Trauma. 2007;62:1339–45. doi:10.1097/TA.0b013e318054e25a.
  • Metting Z, Rodiger LA, Stewart RE, Oudkerk M, DeKeyser J, van der Naalt J. Perfusion CT in the acute phase of mTBI: regional dysfunction and prognostic value. Ann Neurol. 2009;66:809–16. doi:10.1002/ana.21785.
  • Servadei F, Teasdale G, Merry G. Defining mTBI in adults: a proposal based on prognostic factors, diagnosis, and management. J Neurotrauma. 2001;18(7):657–62. doi:10.1089/089771501750357609. PMID: 11497092.
  • Boake C, McCauley SR, Pedroza C, Levin HS, Brown SA, Brundage SI. Lost productive work time after mild to moderate traumatic brain injury with and without hospitalization. Neurosurgery. 2005;56:994–1003. doi:10.1227/01.NEU.0000158319.38230.c3.
  • Belanger HG, Spiegel E, Vanderploeg RD. Neuropsychological performance following a history of multiple self-reported concussions: a meta-analysis. J Int Neuropsychol Soc. 2009;16:262–67. doi:10.1017/s1355617709991287.
  • Ponsford J, Willmott C, Rothwell A, Cameron P, Kelly A, Nelms R, Curran C, Ng K. Factors influencing outcome following mTBI in adults. J Int Neurol Soc. 2000;6(5):568–79. doi:http://dx.doi.org.
  • Millar K, Nicoll JA, Thornhill S, Murray GD, Teasdale GM. Long term neuropsychological outcome after head injury: relation to APOE genotype. J Neurol Neurosurg Psychiatry. 2003;74:1047–52. doi:10.1136/jnnp.74.8.1047. PubMed PMID: 12876232; PubMed Central PMCID: PMC1738588.
  • Ponsford J, Rudzki D, Bailey K, Ng KT. Impact of APOE gene on cognitive impairment and recovery after TBI. Neurology. 2007;68:619–20. doi:10.1212/01.wnl.0000254609.04330.9d.
  • Alexander S, Kerr M, Kim Y, Kamboh M, Beers S, Conley Y. Apolipoprotein E4 allele presence and functional outcome after severe traumatic brain injury. J Neurotrauma. 2007;24(5):790–97. doi:10.1089/neu.2006.0133.
  • Jiang Y, Sun XC, Gui L, Xia Y, Tang W, Cao Y, Gu Y. Correlation between APOE −491AA promoter in e4 carriers and clinical deterioration in early stage of traumatic brain injury. J Neurotrauma. 2007;24:1802–10. doi:10.1089/neu.2007.0299.
  • Han SD, Drake AI, Cessante LM, Jak AJ, Houston WS, Delis DC, Filoteo JV, Bondi MW. Apolipoprotein E and traumatic brain injury in a military population: evidence of a neuropsychological compensatory mechanism. J Neurol Neurosurg Psychiatry. 2007;78(10):1103–08. doi:10.1136/jnnp.2006.108183.
  • Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D. Cognitive domain decline in health APOEe4 homozygotes before the diagnosis of mild cognitive impairment. Arch Neurol. 2007;64:1306–11. doi:10.1001/archneur.64.9.1306.
  • Farlow M, He Y, Tekin S, Xu J, Lane R, Charles H. Impact of APOE in mild cognitive impairment. Neurology. 2004;63(10):1898–901. doi:10.1212/01.wnl.0000144279.21502.b7. Cited in: PMID: 15557508.
  • Zhou W, Xu D, Peng X, Zhang Q, Jia J, Crutcher K. Meta-analysis of APOEe4 allele and outcome after traumatic brain injury. J Neurotrauma. 2008;25:279–90. doi:10.1089/neu.2007.0489. PMID: 18373478.
  • Isoniemi H, Kurki T, Tenovuo O, Kairisto V, Portin R. Hippocampal volume, brain atrophy, and APOE genotype after traumatic brain injury. Neurology. 2006;67:756–60. doi:10.1212/01.wnl.0000234140.64954.12. Cited in: PMID: 16966535.
  • Willemse-van Son A, Ribbers G, Hop W, van Duijin C, Stam J. Association between apolipoprotein e4 and long-term outcome after traumatic brain injury. J Neurol Neurosurg Psychiatry. 2008;79:426–30. doi:10.1136/jnnp.2007.129460.
  • Farrer LA, Cupples LA, Haines JL. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and alzheimer disease: a meta-analysis. JAMA. 1997;278(16):1349–56. doi:10.1001/jama.1997.03550160069041. Cited in: PMID: 9343467.
  • Bishara SN, Partridge FN, Godfrey HP, Knight RG. Post-traumatic amnesia and GCS related to outcome in survivors in a consecutive series of patients with severe closed-head injury. Brain Inj. 1992;6:373–80. Cited in: PMID: 1638271.
  • Asihainen I, Kaste M, Sarna S. Early and late posttraumatic seizures in TBI rehabilitation patients: brain injury factors causing late seizures and influence of seizures on long term outcome. Epilepsia. 1999;40:584–89. Cited in: PMID: 10386527.
  • Sigurdardottir S, Andelic N, Roe C, Schanke A. Cognitive recovery and predictors of functional outcome 1 year after traumatic brain injury. J Int Neuropsychol Soc. 2009;15(5):740–50. doi:https:/doi.10.1017/S1355617709990452.
  • Tellier A, Marshall SC, Wilson KG, Smith A, Perugini M, Stiell IG. The heterogeneity of mild TBI: where do we stand? Brain Inj. 2009;23(11):879–87. doi:10.1080/02699050903200555.
  • Kurca E, Sivak S, Kucera P. Impaired cognitive functions in mild TBI patients with normal and pathologic MRI. Neuroradiology. 2006;48:661–69. doi:10.1007/s00234-006-0109-9. Cited in: PMID: 16786351.
  • Williams DH, Levin HS, Eisenberg HM. Mild head injury classification. Neurosurgery. 1990;27:422–28. doi:10.1097/00006123-199009000-00014.
  • Kamboj SK, Tookman A, Jones L, Curran HV. The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain. 2005;117(3):388–95. doi:10.1016/j.pain.2005.06.022. Cited in: PMID: 16198201.
  • McMorn S, Schoedel K, Sellers E. Effects of low-dose opioids on cognitive dysfunction. J Clin Oncol. 2011;29(32):4342–43. doi:10.1200/JCO.2011.38.2309.
  • Nathoo N, Chetty R, van Dellen JR, Connolly C, Naidoo R. Apolipoprotein E polymorphism and outcome after closed traumatic brain injury: influence of ethnic and regional differences. J Neurosurg. 2003;98:302–06. doi:10.3171/jns.2003.98.2.0302. Cited in: PMID: 12593615.
  • Laskwitz DT, Song P, Wang H, Mace B, Sullivan PM, Vitek MP, Dawson HN. Traumatic brain injury exacerbates neurodegenerative pathology: improvement with an ApoE-based therapeutic. J Neurotrauma. 2010;27:1983–95. doi:10.1089/neu.2010.1396. Cited in: PMID: 20812776.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.